Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analysis: optimizing microneedles for epidermal access

Karl E Friedl1

  • 1U.S. Army Research Institute of Environmental Medicine, Natick, Massachusetts 01760-5007, USA. karl.friedl@us.army.mil

Diabetes Technology & Therapeutics
|June 3, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence Is a Useful Tool in Exercise Science and Sports Medicine: Response to Hando and Colleagues.

Medicine and science in sports and exercise·2026
Same author

Artificial Intelligence in Exercise Science and Sports Medicine.

Medicine and science in sports and exercise·2026
Same author

Beyond reliability: Addressing systematic bias and advancing standardization in bioelectrical impedance analysis.

European journal of clinical nutrition·2026
Same author

Even low levels of physical activity are associated with lower all-cause mortality: A cohort study of 594,000 US adults.

Annals of epidemiology·2026
Same author

Skeletal muscle mass is not compositionally uniform: the role of fluid compartments in health and performance monitoring.

European journal of clinical nutrition·2026
Same author

Training Modality and Aerobic Fitness in Active Duty U.S. Marines.

Military medicine·2026
Same journal

<i>Erratum to:</i> "HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis".

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> Comments on: Real-World Total Daily Insulin Dose in over 14,000 Young Individuals with Type 1 Diabetes in the United States.

Diabetes technology & therapeutics·2026
Same journal

Settings Associated with Optimal Glycemic Outcomes with the Omnipod® 5 Automated Insulin Delivery System: Evidence from Real-World Users with Type 1 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Automated Insulin Delivery Systems in Hospitals: A Systematic Review with Meta-Analysis.

Diabetes technology & therapeutics·2026
Same journal

Predicting Risk for Diabetic Ketoacidosis in Children Recently Diagnosed with Type 1 Diabetes Using the Risk Index for Diabetic Ketoacidosis.

Diabetes technology & therapeutics·2026
Same journal

Association Between Longitudinal Time in Range and Albuminuria in Insulin-Treated Diabetes.

Diabetes technology & therapeutics·2026
See all related articles